These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28645354)

  • 1. [Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion].
    Rochette C; Castinetti F; Brue T
    Ann Endocrinol (Paris); 2016 Oct; 77 Suppl 1():S19-S28. PubMed ID: 28645354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Cushing's disease: a single-center experience.
    Solak M; Kraljevic I; Dusek T; Melada A; Kavanagh MM; Peterkovic V; Ozretic D; Kastelan D
    Endocrine; 2016 Mar; 51(3):517-23. PubMed ID: 26215278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's disease in 2012.
    Obiols Alfonso G; Biagetti Biagetti B; Chacón Oreja A; Salvador Rodríguez J
    Endocrinol Nutr; 2014 Feb; 61(2):93-9. PubMed ID: 24041670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly.
    Psaras T; Milian M; Hattermann V; Freiman T; Gallwitz B; Honegger J
    Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):21-5. PubMed ID: 20827660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-surgical management of hormone-secreting pituitary tumors.
    Patil CG; Hayden M; Katznelson L; Chang SD
    J Clin Neurosci; 2009 Aug; 16(8):985-93. PubMed ID: 19443220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Network for the Enhancement of Endocrinology and Oncology Knowledge: a case-based consideration of current practice in Cushing's disease and acromegaly.
    Biller BM; Sheppard M
    Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23 Suppl 1():S1-4. PubMed ID: 20129189
    [No Abstract]   [Full Text] [Related]  

  • 9. Mortality and pituitary disease.
    Stewart PM; Sherlock M
    Ann Endocrinol (Paris); 2012 Apr; 73(2):81-2. PubMed ID: 22503666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous remission of acromegaly and Cushing's disease in older patients. Report of two cases].
    Araya AV; Eugenin D; Lemp M
    Rev Med Chil; 2018 Jul; 146(7):933-937. PubMed ID: 30534895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous remission of acromegaly and Cushing's disease following pituitary apoplexy: Two case reports.
    Roerink SH; van Lindert EJ; van de Ven AC
    Neth J Med; 2015 Jun; 73(5):242-6. PubMed ID: 26087804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks of overlooking the diagnosis of secreting pituitary adenomas.
    Brue T; Castinetti F
    Orphanet J Rare Dis; 2016 Oct; 11(1):135. PubMed ID: 27716353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities in Cushing's disease.
    Sharma ST; Nieman LK; Feelders RA
    Pituitary; 2015 Apr; 18(2):188-94. PubMed ID: 25724314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the outcomes of the treatment of Cushing's disease in the hospitals of Castilla-La Mancha.
    Huguet I; Aguirre M; Vicente A; Alramadan M; Quiroga I; Silva J; Lamas C
    Endocrinol Nutr; 2015 May; 62(5):217-23. PubMed ID: 25842035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.
    Zacharieva S; Orbetzova M; Stoynev A; Shigarminova R; Yaneva M; Kalinov K; Nachev E; Elenkova A
    J Endocrinol Invest; 2004 Nov; 27(10):924-30. PubMed ID: 15762039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardivascular Risk Profile in Patients with Diabetes and Acromegaly or Cushing's Disease - Analysis from the DPV Database.
    Warncke K; Kummer S; Kann PH; Bergis D; Bollow E; Hummel M; Zoicas F; Wernert S; Holl RW
    Exp Clin Endocrinol Diabetes; 2020 Feb; 128(2):104-110. PubMed ID: 30332686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR-gamma in Cushing's disease.
    Heaney AP
    Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrent Cushing's disease.
    Liubinas SV; Porto LD; Kaye AH
    J Clin Neurosci; 2011 Jan; 18(1):7-12. PubMed ID: 20851608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life in Cushing's disease: A long term issue?
    Webb SM; Santos A; Resmini E; Martínez-Momblán MA; Martel L; Valassi E
    Ann Endocrinol (Paris); 2018 Jun; 79(3):132-137. PubMed ID: 29625700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.